BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumari S, Dandamudi M, Rani S, Behaeghel E, Behl G, Kent D, O'Reilly NJ, O'Donovan O, McLoughlin P, Fitzhenry L. Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease. Pharmaceutics 2021;13:905. [PMID: 34207223 DOI: 10.3390/pharmaceutics13060905] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Das B, Nayak AK, Mallick S. Lipid-based nanocarriers for ocular drug delivery: An updated review. Journal of Drug Delivery Science and Technology 2022;76:103780. [DOI: 10.1016/j.jddst.2022.103780] [Reference Citation Analysis]
2 Chauhan A, Fitzhenry L, Serro AP. Recent Advances in Ophthalmic Drug Delivery. Pharmaceutics 2022;14:2075. [DOI: 10.3390/pharmaceutics14102075] [Reference Citation Analysis]
3 Zafar A, Alsaidan OA, Imam SS, Yasir M, Alharbi KS, Khalid M. Formulation and Evaluation of Moxifloxacin Loaded Bilosomes In-Situ Gel: Optimization to Antibacterial Evaluation. Gels 2022;8:418. [DOI: 10.3390/gels8070418] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. Current trends in pharmaceutical treatment of Dry Eye Disease: A review. Eur J Pharm Sci 2022;:106206. [PMID: 35568107 DOI: 10.1016/j.ejps.2022.106206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Madamsetty VS, Mohammadinejad R, Uzieliene I, Nabavi N, Dehshahri A, García-Couce J, Tavakol S, Moghassemi S, Dadashzadeh A, Makvandi P, Pardakhty A, Aghaei Afshar A, Seyfoddin A. Dexamethasone: Insights into Pharmacological Aspects, Therapeutic Mechanisms, and Delivery Systems. ACS Biomater Sci Eng 2022;8:1763-90. [PMID: 35439408 DOI: 10.1021/acsbiomaterials.2c00026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo Q, Yang J, Xu H, Shi J, Liang Z, Zhang R, Lu P, Pu G, Zhao N, Zhang J. Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study. Drug Delivery 2022;29:837-55. [DOI: 10.1080/10717544.2022.2048134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Bonetti FMR, de Paula E, Fonseca BB, da Silva GR, da Silva LSS, de Moura LD, Breitkreitz MC, Rodrigues da Silva GH, de Morais Ribeiro LN. Hybrid Nanobeads for Oral Indomethacin Delivery. Pharmaceutics 2022;14:583. [DOI: 10.3390/pharmaceutics14030583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chen X, Wu J, Lin X, Wu X, Yu X, Wang B, Xu W. Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment. Front Pharmacol 2022;13:838168. [PMID: 35185587 DOI: 10.3389/fphar.2022.838168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ling J, Chan BC, Tsang MS, Gao X, Leung PC, Lam CW, Hu J, Wong CK. Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine. Front Med 2022;8:815075. [DOI: 10.3389/fmed.2021.815075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 López-Machado A, Díaz-Garrido N, Cano A, Espina M, Badia J, Baldomà L, Calpena AC, Souto EB, García ML, Sánchez-López E. Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation. Pharmaceutics 2021;13:1698. [PMID: 34683990 DOI: 10.3390/pharmaceutics13101698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]